Articles
Could this psychedelic compound reduce post-concussion symptoms?
Few effective therapies exist for concussion. Now, an Australian clinical trial is exploring whether a psychedelic compound found in some mushrooms could help. [ + ]
Prototype promises to build light analysis directly into imaging hardware
Thanks to a new chip, researchers believe they may be able to help cameras capture details that typically required separate, specialised instruments. [ + ]
Ultrasound improves protein recovery from cauliflower waste
Abundant but often discarded during processing, cauliflower leaves contain protein and dietary fibre. Now, Australian scientists have explored reuse potential. [ + ]
Turning point — optimal antibiotics for golden staph bloodstream infections
Involving more than 150 hospitals across more than 14 countries, a global clinical trial supports a rethink of the default treatment for MSSA and PSSA infections. [ + ]
Clinical trials could be "cancelled" under controversial Budget proposals — survey suggests
A survey of 59 biotech, medtech and health tech companies has found that 66% believe they will be 'worse off' under proposed R&D Tax Incentive Budget changes. [ + ]
From waste CO2 into valuable chemicals
An Australian-designed electrochemical generator promises a safer and more environmentally friendly pathway to convert waste CO2 into useful products. [ + ]
Alloy implants that naturally dissolve after healing
Australian researchers have been developing biodegradable magnesium-based alloys that more closely match the mechanical properties of human bone. [ + ]
Scientific rigour within a person-centred, biophilic setting
The $96 million, 4500-square-metre RNA Research and Manufacturing Facility has opened within the Macquarie University Innovation Precinct. [ + ]
Irregular blood pressure patterns and dementia-associated brain changes
Hypertension has long been recognised as a risk factor for cognitive decline, yet the impact of blood pressure changes throughout the day has been less understood. [ + ]
Sydney's $490m commercial life sciences precinct gets first tenants
ION, a dedicated, purpose-built commercial life sciences precinct located in Waterloo, has secured its inaugural partners. [ + ]
How an Alzheimer's-linked protein shapes long-term memories
Tau, a protein widely associated with memory loss in dementia, has been shown to be essential for organising and stabilising memories so they persist over time. [ + ]
Could 'fusion proteins' reduce errors in a promising gene-editing tool?
Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies. Now, Australian scientists believe they've made it safer. [ + ]
Giant squid found hidden in submarine canyons off Western Australia
Using eDNA, Australian scientists have found hidden biodiversity off the WA coast, including the elusive Architeuthis dux and species possibly new to science. [ + ]
Potential biological targets for vascular dementia
Caused by damage to blood vessels in the brain, there is currently no approved treatment for vascular dementia. Could genetics-led approaches offer pathways? [ + ]
Can yawning advance the study of neurodegenerative diseases?
Australian neuroscientists using MRI scans to monitor flow of cerebrospinal fluid during yawning believe their findings may assist neurodegenerative disease studies. [ + ]
